Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,002 public trials 1,214 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors

NCT00137774

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Insitute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer

NCT00014573

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +25 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma

NCT00238329

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma

NCT00004022

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

NCT00004024

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma

NCT00091143

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Providence Cancer Center at Providence Portland Medical Center Portland, Oregon, United States

View Trial Details

Completed

Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma

NCT00005637

Conditions: Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +15 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Immunoreactivity to Cetuximab in Cancer Patients

NCT00896896

Conditions: Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +34 more
Locations: Not specified

View Trial Details

Completed

Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma

NCT00354068

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations: Duke Cancer Institute Durham, North Carolina, United States

View Trial Details

Completed

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

NCT00060372

Conditions: Adnexal Diseases, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +148 more
Locations: Scripps Clinic - La Jolla La Jolla, California, United States

University of California San Diego La Jolla, California, United States

Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

Northside Hospital Atlanta, Georgia, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions